Home›Trial›NCT04985487
🔬NCT04985487RECRUITING

Regulatory Post-Marketing Surveillance Study for Brolucizumab

Study Summary

This study is an open-label, multicenter, single-arm, observational post-marketing surveillance.

Conditions
Neovascular Age-related Macular Degeneration
Interventions / Drugs
brolucizumab
View on ClinicalTrials.gov ↗
Sponsor
NVS
Novartis AG
Diversified Pharma
D36/100
Study Details
Enrollment3000 participants
Primary Completion—
Lead SponsorNovartis Pharmaceuticals
Data Retrieved2026-04-11 02:55:49.151381+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.